FDA Inspection 1149615 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on July 30, 2021 in Jayuya, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jayuya, PR (United States)